News Image

Investors seeking growth at a reasonable cost should explore NASDAQ:TGTX.

By Mill Chart

Last update: Oct 30, 2024

Here's TG THERAPEUTICS INC (NASDAQ:TGTX) for you, a growth stock our stock screener believes is undervalued. NASDAQ:TGTX is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.


Affordable Growth stocks image

Growth Assessment of NASDAQ:TGTX

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:TGTX has received a 8 out of 10:

  • TGTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 147.24%, which is quite impressive.
  • The Revenue has grown by 1338.63% in the past year. This is a very strong growth!
  • The Revenue has been growing by 335.01% on average over the past years. This is a very strong growth!
  • Based on estimates for the next years, TGTX will show a very strong growth in Earnings Per Share. The EPS will grow by 229.97% on average per year.
  • The Revenue is expected to grow by 41.13% on average over the next years. This is a very strong growth

Analyzing Valuation Metrics

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:TGTX has earned a 6 for valuation:

  • 94.83% of the companies in the same industry are more expensive than TGTX, based on the Price/Earnings ratio.
  • Based on the Price/Forward Earnings ratio, TGTX is valued cheaply inside the industry as 93.58% of the companies are valued more expensively.
  • Based on the Enterprise Value to EBITDA ratio, TGTX is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TGTX is valued cheaply inside the industry as 95.01% of the companies are valued more expensively.
  • TGTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TGTX's earnings are expected to grow with 439.37% in the coming years.

What does the Health looks like for NASDAQ:TGTX

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NASDAQ:TGTX has earned a 7 out of 10:

  • An Altman-Z score of 7.79 indicates that TGTX is not in any danger for bankruptcy at the moment.
  • TGTX has a Altman-Z score of 7.79. This is amongst the best in the industry. TGTX outperforms 81.64% of its industry peers.
  • The Debt to FCF ratio of TGTX is 1.51, which is an excellent value as it means it would take TGTX, only 1.51 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TGTX (1.51) is better than 96.26% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for TGTX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
  • TGTX has a Current Ratio of 3.58. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.
  • TGTX has a Quick Ratio of 2.83. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.

A Closer Look at Profitability for NASDAQ:TGTX

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:TGTX was assigned a score of 5 for profitability:

  • TGTX's Return On Assets of 23.84% is amongst the best of the industry. TGTX outperforms 98.75% of its industry peers.
  • TGTX has a better Return On Equity (53.87%) than 99.29% of its industry peers.
  • The Return On Invested Capital of TGTX (27.51%) is better than 99.47% of its industry peers.
  • TGTX has a Profit Margin of 27.59%. This is amongst the best in the industry. TGTX outperforms 97.86% of its industry peers.
  • The Operating Margin of TGTX (29.38%) is better than 98.22% of its industry peers.
  • TGTX has a Gross Margin of 92.76%. This is amongst the best in the industry. TGTX outperforms 94.47% of its industry peers.

More Affordable Growth stocks can be found in our Affordable Growth screener.

Check the latest full fundamental report of TGTX for a complete fundamental analysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

TG THERAPEUTICS INC

NASDAQ:TGTX (12/6/2024, 8:17:33 PM)

After market: 33.99 +0.06 (+0.18%)

33.93

+0.28 (+0.83%)

Follow us for more